We are live on ! Find out more
AA

AQR Arbitrage Portfolio holdings

AUM $6.09B
1-Year Est. Return 27.01%
This Fund
S&P 500
This Quarter Est. Return
+7.86%
1 Year Est. Return
+27.01%
3 Year Est. Return
+77.25%
5 Year Est. Return
+160.09%
10 Year Est. Return
+1,244.43%
AUM
$2.78B
AUM Growth
-$65.9M
Cap. Flow
-$1.1B
Cap. Flow %
-39.55%
Top 10 Hldgs %
16.2%
Holding
1,575
New
503
Increased
22
Reduced
219
Closed
602

Sector Composition

Rank Sector Weight
1 Financials 10.51%
2 Healthcare 6.47%
3 Industrials 4.82%
4 Consumer Discretionary 4.5%
5 Technology 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PV.U
526
DELISTED
Primavera Capital Acquisition Corporation Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
PV.U
$420K 0.02%
+41,000
New +$439K
BRPAR
527
DELISTED
Big Rock Partners Acquisition Corp. Right
BRPAR
$420K 0.02%
200,000
SNRH
528
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
$418K 0.02%
+43,000
New +$434K
MYD
529
DELISTED
BlackRock MuniYield Fund
MYD
$417K 0.02%
29,075
-16,265
-36% -$233K
JCIC
530
DELISTED
Jack Creek Investment Corp. Class A Ordinary Shares
JCIC
$417K 0.02%
+43,198
New +$419K
SLCR
531
DELISTED
Silver Crest Acquisition Corporation Class A Ordinary Share
SLCR
$417K 0.02%
+42,998
New +$418K
ABGI
532
DELISTED
ABG Acquisition Corp. I
ABGI
$415K 0.01%
+42,000
New +$422K
FINM
533
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
$415K 0.01%
+43,215
New +$421K
PDYN icon
534
Palladyne AI
PDYN
$240M
$413K 0.01%
+7,028
New +$411K
NIR
535
DELISTED
Near Intelligence, Inc. Common Stock
NIR
$412K 0.01%
+42,332
New +$415K
MILEW
536
DELISTED
Metromile, Inc. Warrant
MILEW
$412K 0.01%
133,332
SVFA
537
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$408K 0.01%
+39,995
New +$471K
ZGYH
538
DELISTED
Yunhong International Class A Ordinary Shares
ZGYH
$407K 0.01%
40,572
-9,428
-19% -$95.4K
LFLYW
539
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$405K 0.01%
349,563
-25,437
-7% -$42.3K
KPLTW
540
DELISTED
Katapult Holdings Warrant
KPLTW
$403K 0.01%
116,948
-383,052
-77% -$1.66M
BWAC
541
DELISTED
BETTER WORLD ACQUISITION CORP. Common Stock
BWAC
$403K 0.01%
+40,500
New +$417K
GMBTU
542
DELISTED
Pivotal Holdings Corp Unit
GMBTU
$403K 0.01%
+40,000
New +$424K
NCV
543
Virtus Convertible & Income Fund
NCV
$374M
$402K 0.01%
+17,765
New +$410K
DLCA
544
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
$402K 0.01%
+41,000
New +$401K
PAQC
545
DELISTED
Provident Acquisition Corp. Class A Ordinary Shares
PAQC
$401K 0.01%
+40,998
New +$404K
TALKW
546
DELISTED
Talkspace Inc Warrant
TALKW
$399K 0.01%
275,000
SDST
547
Stardust Power Inc
SDST
$15.2M
$399K 0.01%
+4,100
New +$407K
BRMK.WS
548
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$399K 0.01%
1,750,000
CENHU
549
DELISTED
Centricus Acquisition Corp. Unit
CENHU
$398K 0.01%
+40,000
New +$408K
MACAU
550
DELISTED
Moringa Acquisition Corp Units
MACAU
$397K 0.01%
+40,000
New +$408K

Similar funds

AQR Arbitrage's Q1 2021 Portfolio in Review

As of Q1 2021, AQR Arbitrage held 1,575 positions worth $2.78B, down 2.3% from $2.85B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

AQR Arbitrage withdrew a net $1.1B in Q1 2021, closing 602 positions and reducing 219 holdings. Its most notable exit was Eidos Therapeutics, Inc. Common Stock, an estimated $36.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 9% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AQR Arbitrage opened a new position in Cantel Medical Corporation worth $33.4M.

  • AQR Arbitrage's largest Q1 2021 buy was Cantel Medical Corporation: 420,838 shares worth $33.4M.
  • AQR Arbitrage added most to PRA Health Sciences, Inc. in Q1 2021, an estimated $23.3M increase.
  • AQR Arbitrage's biggest Q1 2021 reduction was International Flavors & Fragrances Inc. 6.00% Tangible Equity Units, cutting an estimated $12.5M.
  • AQR Arbitrage fully exited Eidos Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $36.2M.
  • AQR Arbitrage's ten largest holdings make up 16% of its $2.78B portfolio in Q1 2021.
  • AQR Arbitrage opened 503 new positions and closed 602 in Q1 2021.
  • AQR Arbitrage's portfolio value fell 2.3% quarter-over-quarter to $2.78B.

Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.